**Core Concept:** Long-acting dopamine agonists are medications that mimic the effects of dopamine, a neurotransmitter involved in regulating movement, mood, and cognition. They are used in the treatment of Parkinson's disease and other conditions involving dopamine deficiency.

**Why the Correct Answer is Right:** Pramipexole (Option D) is a long-acting dopamine agonist. It acts specifically on D2 dopamine receptors, enhancing dopaminergic activity in the brain. This helps to alleviate symptoms of Parkinson's disease and restless leg syndrome.

**Why Each Wrong Option is Incorrect:**

A. Apomorphine (Option C) is a short-acting dopamine agonist. Unlike pramipexole, it does not require continuous subcutaneous infusion due to its rapid clearance from the body.

B. Bromocriptine (Option B) is another short-acting dopamine agonist used in the treatment of Parkinson's disease. It primarily acts on D2 and D3 dopamine receptors, with some affinity for serotonin receptors.

**Clinical Pearl:**
Dopamine agonists are typically used in combination with levodopa, a precursor to dopamine, to enhance its effectiveness in treating Parkinson's disease. This combination, known as levodopa-dopa agonist therapy, improves motor symptoms and overall patient quality of life.

**Correct Answer:** Dopamine agonists are typically classified as either long-acting or short-acting based on their pharmacokinetic and pharmacodynamic properties. Pramipexole (Option D) is a long-acting dopamine agonist used in the treatment of Parkinson's disease and restless leg syndrome.